Skip to content

LivaNova LIVN Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Abbott logo
AbbottABT
ITG
Integer HoldingsITGR
ResMed logo
ResMedRMD
Boston Scientific logo
Boston ScientificBSX
Baxter International logo
Baxter InternationalBAX
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's treasury stock, shares (in shares)?
LivaNova (LIVN) reported treasury stock, shares (in shares) of $636.43K in Q1 2026.
How has LivaNova's treasury stock, shares (in shares) changed year-over-year?
LivaNova's treasury stock, shares (in shares) decreased by 30.7% year-over-year, from $918.22K to $636.43K.
What is the long-term trend for LivaNova's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), LivaNova's treasury stock, shares (in shares) has grown at a 15.5% compound annual growth rate (CAGR), from $498.21K to $886.1K.